| __timestamp | Takeda Pharmaceutical Company Limited | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 520990000000 | 1717000000 |
| Thursday, January 1, 2015 | 535405000000 | 1738000000 |
| Friday, January 1, 2016 | 558755000000 | 1666000000 |
| Sunday, January 1, 2017 | 495921000000 | 1775000000 |
| Monday, January 1, 2018 | 659690000000 | 1911000000 |
| Tuesday, January 1, 2019 | 1089764000000 | 1992000000 |
| Wednesday, January 1, 2020 | 994308000000 | 2057000000 |
| Friday, January 1, 2021 | 1106846000000 | 2303000000 |
| Saturday, January 1, 2022 | 1244072000000 | 2454000000 |
| Sunday, January 1, 2023 | 1431505000000 | 2710000000 |
| Monday, January 1, 2024 | 1431505000000 | 2719000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue for two major players: Zoetis Inc. and Takeda Pharmaceutical Company Limited, from 2014 to 2023. Over this period, Takeda's cost of revenue surged by approximately 175%, peaking at 1.43 trillion in 2023. In contrast, Zoetis Inc. experienced a more modest increase of around 58%, reaching 2.71 billion in the same year. Notably, Takeda's cost of revenue consistently dwarfs that of Zoetis, highlighting the scale of its operations. However, the data for 2024 is incomplete, indicating potential shifts in the coming years. This comparative analysis provides a window into the financial strategies of these pharmaceutical giants, offering insights into their operational efficiencies and market positioning.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Takeda Pharmaceutical Company Limited
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Zoetis Inc. vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited's Expenses
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Mesoblast Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Xencor, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.